The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports and stock price the company's current Operating Margin is 34.59%. At the end of 2022 the company had an Operating Margin of 27.91%.
Year | Operating Margin | Change |
---|---|---|
2022 | 27.91% | 8.19% |
2021 | 25.79% | -19.37% |
2020 | 31.99% | -18.22% |
2019 | 39.11% | -2.69% |
2018 | 40.19% | -4.3% |
2017 | 42.00% | 5.39% |
2016 | 39.85% | 8.21% |
2015 | 36.83% | 32.3% |
2014 | 27.84% | -1.26% |
2013 | 28.19% | -2.83% |
2012 | 29.01% | 8.93% |
2011 | 26.63% | -24.6% |
2010 | 35.32% | -0.62% |
2009 | 35.54% | 1.57% |
2008 | 34.99% | 30.49% |
2007 | 26.82% | -4.82% |
2006 | 28.17% | -28.06% |
2005 | 39.16% | 21.7% |
2004 | 32.18% | -15.26% |
2003 | 37.97% | -406.4% |
2002 | -12.39% | -129.51% |
2001 | 41.99% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | 22.88% | -33.85% | ๐บ๐ธ USA |
![]() Pfizer PFE | 34.61% | 0.06% | ๐บ๐ธ USA |
![]() AbbVie ABBV | 18.65% | -46.08% | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 24.66% | -28.71% | ๐บ๐ธ USA |
![]() Biogen BIIB | 31.30% | -9.51% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 26.84% | -22.41% | ๐บ๐ธ USA |
![]() Illumina ILMN | -94.58% | -373.43% | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 19.24% | -44.38% | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 22.54% | -34.84% | ๐ฌ๐ง UK |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.